Abstract
Summary
We investigated the association between celiac disease (CD) and bone mass density (BMD) and risk of osteoporotic fractures in the general US population. In children and men ≥18 years, CD was associated with reduced BMD, and in men ≥40 years, CD was associated with increased risk of osteoporotic fractures.
Introduction
Celiac disease (CD) is an autoimmune condition, characterized by inflammation of the small intestine. CD has an increasing prevalence, and if unrecognized or untreated, CD can lead to complications from malabsorption and micronutrient deficiencies. We aimed to study whether CD is an independent predictor of reduced bone mineral density (BMD) and FRAX scores in the general US population.
Methods
We used data from the National Health and Nutrition Examination Survey, 2009–2010 and 2013–2014. CD was defined by positive tissue transglutaminase IgA antibody test. Multivariable models of BMD and FRAX scores were adjusted for BMI, serum 25-hydroxyvitamin D, vitamin D and calcium supplements, milk intake, serum calcium, and smoking status, when available.
Results
In children, aged 8–17 years, CD was associated with decreased Z-scores, by 0.85 for hip and 0.46 for spine (both P < 0.001). In men aged ≥ 18 years, CD was associated with 0.06 g/cm2 decrease in BMD in hip and with 0.11 g/cm2 decrease in BMD in spine (P = 0.08 and P < 0.001, respectively). In women, there were no statistically significant differences in the multiple-adjusted model. In men aged ≥ 40 years, CD predicted FRAX scores, resulting in increased scores by 2.25 % (P = 0.006) for hip fracture and by 2.43 % (P = 0.05) for major osteoporotic fracture. CD did not predict FRAX scores in women aged ≥40 years.
Conclusion
CD is independently associated with reduced BMD in children and adults aged ≥18 years and is an independent risk factor of osteoporotic fractures in men aged ≥40 years.
Similar content being viewed by others
References
Ludvigsson J, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, Green PH, Hadjivassiliou M, Holdoway A, van Heel DA, Kaukinen K, Leffler DA, Leonard JN, Lundin KE, McGough N, Davidson M, Murray JA, Swift GL, Walker MM, Zingone F, Sanders DS (2014) Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 63(8):1210–1228. doi:10.1136/gutjnl-2013-306578
Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C (2013) The Oslo definitions for coeliac disease and related terms. Gut 62:43–52. doi:10.1136/gutjnl-2011-301346
Mearin ML (2007) Celiac disease among children and adolescents. Curr Probl Pediatr Adolesc Health Care 37:86–105
Zanchetta MB, Longobardi V, Bai JC (2016) Bone and celiac disease. Curr Osteoporos Rep. doi:10.1007/s11914-016-0304-5
Bianchi ML (2010) Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys 503:54–65. doi:10.1016/j.abb.2010.06.026
Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684–694. doi:10.1136/gut.2006.117382
Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, Passariello R, Cucchiara S (2007) Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13:416–423
Lucendo AJ, García-Manzanares A (2013) Bone mineral density in adult coeliac disease: an updated review. Rev Esp Enferm Dig 105:154–162
Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E (2012) Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 60:870–874. doi:10.1016/j.cyto.2012.07.032
Vassallo MF, Camargo CA Jr (2010) Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children. J Allergy Clin Immunol 126:271–222. doi:10.1016/j.jaci.2010.06.011
Plugis NM, Khosla C (2015) Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol 29:503–521. doi:10.1016/j.bpg.2015.04.005
Mardini HE, Westgate P, Grigorian AY (2015) Racial differences in the prevalence of celiac disease in the US population: National Health and Nutritional Examination Survey (NHANES) 2009-2012. Dig Dis Sci 60:1738–1742. doi:10.1007/s10620-014-3514-7
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE (2012) The prevalence of celiac disease in the United States. Am J Gastroenterol 107:1538–1544 . doi:10.1038/ajg.2012.219quiz 1537, 1545
Choung RS, Ditah IC, Nadeau AM, Rubio-Tapia A, Marietta EV, Brantner TL, Camilleri MJ, Rajkumar V, Landgren O, Everhart JE, Murray JA (2015) Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110:455–461. doi:10.1038/ajg.2015.8
Calvo MS, Whiting SJ, Barton CN (2004) Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80(Suppl):1710S–1716S
Jansen MA, Kiefte-de Jong JC, Gaillard R, Escher JC, Hofman A, Jaddoe VW, Hooijkaas H, Moll HA (2015) Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study. Clin Gastroenterol Hepatol 13:913–920. doi:10.1016/j.cgh.2014.09.032
Margoni D, Chouliaras G, Duscas G, Voskaki I, Voutsas N, Papadopoulou A, Panayiotou J, Roma E (2012) Bone health in children with celiac disease assessed by dual x-ray absorptiometry: effect of gluten-free diet and predictive value of serum biochemical indices. J Pediatr Gastroenterol Nutr 54:680–684. doi:10.1097/MPG.0b013e31823f5fc5
Hadjivassilliou M, Rao DG, Grünewald RA, Aeschlimann DP, Sarrigiannis PG, Hoggard N, Aeschlimann P, Mooney PD, Sanders DS (2016) Neurological dysfunction in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol. doi:10.1038/ajg.2015.434
Agardh D, Björck S, Agardh CD, Lidfeldt J (2009) Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women. Scand J Gastroenterol 44:571–578. doi:10.1080/00365520902718929
Meyer D, Stavropolous S, Diamond B, Shane E, Green PH (2001) Osteoporosis in a north american adult population with celiac disease. Am J Gastroenterol 96:112–119
Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Föger-Samwald U, Ellinger I (2016) Immunology of osteoporosis: a mini review. Gerontology 62:128–137. doi:10.1159/000431091
Mori G, D’Amelio P, Faccio R, Brunetti G (2015) Bone-Immune cell crosstalk: Bone diseases. J Immunol Res. doi:10.1155/2015/108451
Roy B (2013) Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. World J Diabetes 4:101–113. doi:10.4239/wjd.v4.i4.101
Demirdal US, Ciftci IH, Kavuncu V (2010) Markers of autoimmune liver diseases in postmenopausal women with osteoporosis. Clinics 65:971–974. doi:10.1590/S1807-59322010001000008
Schøsler L, Christensen LA, Hvas CL (2016) Symptoms and findings in adult-onset celiac disease in a historical Danish patient cohort. Scand J Gastroenterol 51:288–264. doi:10.3109/00365521.2015.1092576
Heikkilä K, Heliövaara M, Impivaara O, Kröger H, Knekt P, Rissanen H, Mäki M, Kaukinen K (2015) Celiac disease autoimmunity and hip fracture risk: findings from a prospective cohort study. J Bone Miner Res 30:630–636. doi:10.1002/jbmr.2380
Levy MA, McKinnon T, Barker T, Dern A, Helland T, Robertson J, Cuomo J, Wood T, Dixon BM (2015) Predictors of vitamin D status in subjects that consume a vitamin D supplement. Eur J Clin Nutr 69:84–89. doi:10.1038/ejcn.2014.133
Lewiecki EM (2015) Osteoporosis: clinical evaluation. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. http://www.ncbi.nlm.nih.gov/books/NBK279049/
Dawson-Hughes B, National Osteoporosis Foundation Guide Committee (2008) A revised clinician’s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 93:2463–2465. doi:10.1210/jc.2008-0926
LeBoff MS, Cobb H, Gao LY, Hawkes W, Yu-Yahiro J, Kolatkar NS, Magaziner J (2013) Celiac disease in women with hip fractures. J Nutr Health Aging 17:562–565. doi:10.1017/s12603-013-0017-8
Lötters FJB, van den Bergh JP, Vries F, MPMH R-v M (2016) Current and future incidence and costs of osteoporosis-related fractures in the Netherlands: combining claims data with BMD measurements. Calcif Tissue Int 98:235–243. doi:10.1007/s00223-015-0089-z
Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ 3rd (2003) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001–1005
Sernbo I, Johnell O (1993) Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int 3:148–153
Ryan CS, Petkov VI, Adler RA (2011) Osteoporosis in men: the value of laboratory testing. Osteoporos Int 22:1845–1853. doi:10.1007/s00198-010-1421-0
Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:1802–1822. doi:10.1210/jc.2011-3045
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. doi:10.1007/s00198-014-2794-2
Banu J (2013) Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther 7:849–860. doi:10.2147/DDDT.S46101
Acknowledgments
We are grateful to Professor Rolf Jorde from the Department of Endocrinology, Medical Clinic, University Hospital of North Norway, for his assistance with calculation and interpretation of Z-scores and FRAX scores.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Kamycheva, E., Goto, T. & Camargo, C.A. Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey. Osteoporos Int 28, 781–790 (2017). https://doi.org/10.1007/s00198-016-3791-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3791-4